PD-5 MONEO: Phase II study of avelumab (Av) plus FLOT in the peri-operative treatment for patients (pts) with resectable gastric or gastroesophageal junction cancer (GC)

Autor: Alsina, M. 1, Ponz-Sarvise, M. 2, Garcia, D. Lopez 3, Villacampa, G. 4, De Andrea, C. 5, Ochoa, C. 6, López-Janeiro, A. 6, Jiménez-Fonseca, P. 7, Arrazubi, V. 7, García, M. Díez 8, Sanz-García, E. 9, Martinez de Castro, E. 10, Sanchez, R. Guardeño 11, Campos, M. Calvo 12, Sánchez, C. Bugés 13, Longo, F. 14, Navarro, V. 4, Gros, A. 15, Vivancos, A. 16, Tabernero, J. 17, Muñoz, S. 3, Melero, I. 18
Zdroj: In Annals of Oncology June 2023 34 Supplement 1:S2-S3
Databáze: ScienceDirect